Role of 18F-choline PET/CT in evaluation of patients with prostate carcinoma
By: Marina Hodolic
Open Access
|Nov 2010References
- Reske SN. Nuclear imaging of prostate cancer: current status.2007;:
- Kragelj B. Increased late urinary toxicity with whole pelvic radiotherapy after prostatectomy.2009;: 88-96.
- Avazpour I, Roslan RE, Bayat P, Saripan MI, Nordin AJ, Abdullah RSAR. Segmenting CT images of bronchogenic carcinoma with bone metastases using PET intensity markers approach.2009;: 180-6.
- Naji M, Hodolic M, El-Refai S, Khan S, Marzola MC, Rubello D, et al. Endocrine tumors: the evolving role of positron emission tomography in diagnosis and management.2010;: 54-60.
- Watanabe H, Kanematsu M, Kondo H, Kako N, Yamamoto N, Yamada T, et al. Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.2010;: 1151-6.
- Talbot JN, Gutman F, Huchet V, Kerrou K, Balogova S, Kerrouche N, et al. [Clinical usefulness of positron emission tomography in prostate cancer]. [French].2007;: 1794-806.
- Schillaci O, Calabria F, Tavolozza M, Ciccio C, Carlani M, Caracciolo CR, et al. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.2010;: 39-4.
- Le C, van de Weijer EP, Pos FJ, Vogel W. Active inflammation in 18F-methylcholine PET/CT.2010;: 654-5.
- Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.2006;: 262-9.
- Steiner Ch, Vees H, Zaidi H, Wissmeyer M, Berrebi O, Kossovsky MP, et al. Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence.2009;: 1-9.
- Langsteger W, Heinisch M, Fogelman I. The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.2006;: 73-92.
- Beheshti M, Imamovic L, Broinger G, Vali R, Waldenberger P, Stoiber F, et al. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.2010;: 925-33.
- Igerc I, Kohlfurst S, Gallowitsch HJ, Matschnig S, Kresnik E, Gomez-Segovia I, et al. The value of 18F-choline PET/CT in patients with elevated PSA-level and negative prostate needle biopsy for localisation of prostate cancer.2008;: 976-83.
- Beheshti M, Vali R, Waldenberger P, Fitz F, Nader M, Loidl W, et al. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.2008;: 1766-74.
- Horvat AG, Kovac V, Strojan P. Radiotherapy in palliative treatment of painful bone metastases.2009;: 213-24.
- Reske SN; Blumstein NM; Glatting G. PET and PET/CT in relapsing prostate carcinoma.2006;: 1240-50.
- Pelosi E, Arena V, Skanjeti A, Pirro V, Douroukas A, Pupi A, et al. Role of whole-body 18F-choline PET/CT in disease detection in patients with biochemical relapse after radical treatment for prostate cancer.2008;: 895-904.
- Cimitan M, Bortolus R, Morassut S, Canzonieri V, Garbeglio A, Baresic T, et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.2006;: 1387-98.
- Yamamoto Y, Nishiyama Y, Kameyama R, Okano K, Kashiwagi H, Deguchi A, et al. Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.2008;: 1245-8.
Language: English
Page range: 17 - 21
Published on: Nov 25, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2010 Marina Hodolic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.